Biotech Innovation and Bayh-Dole: A Fireside Chat with Gillian M. Fenton
Brought to you by
Please join CSIS on Monday, June 24th from 10:00 to 10:30 am ET for a fireside chat with Gillian M. Fenton, former President of the Licensing Executives Society and Special Counsel for Innovation and Government Collaboration at GSK. Gillian will be joined by Dr. Walter G. Copan, Senior Adviser (Non-Resident) with Renewing American Innovation and former Director of the National Institute of Standards and Technology (NIST), to discuss how the Bayh-Dole Act promotes innovation in the biotech industry and fits into the United States' broader economic security agenda.
This event is made possible by general support to LeadershIP.
More on the Bayh-Dole Act
The Use of March-In Rights Could Undermine Innovation and National Security
Commentary by Hideki Tomoshige and Sujai Shivakumar — May 23, 2024
Proposed Federal Use of March-in Rights Would Weaken American Innovation
Blog Post by Sujai Shivakumar and Thomas Howell — December 20, 2023
The Legacy of Bayh-Dole's Success on U.S. Global Competitiveness Today
Blog Post by Gabrielle Athanasia — January 12, 2022
March-In Rights and U.S. Global Competitiveness
Critical Questions by Alexander Kersten and Gabrielle Athanasia — March 24, 2022
Hosted By
Contact Information
- Chris Borges
- Program Manager and Associate Fellow, Economics Program and Scholl Chair for International Business
- cborges@csis.org